The long follow-up is informative, but the survival comparison was not statistically significant and baseline differences limit a direct procedural comparison.
Read the brief
ClinicalTrials.gov lists IVI-RETRACT (NCT07481500), a randomized comparison of eyelid speculum and cotton-tipped applicator retraction for intravitreal injections, as active but no longer recruiting. Enrollment is now 129 actual participants, up from 120 estimated; estimated primary completion moved from June 2027 to 7 October 2026. No results are posted.
ClinicalTrials.gov ↗The EMA Vabysmo record is the authoritative entry point for EU product information, assessment documents and authorised indications.
European Medicines Agency ↗At ESCRS 2026, ZEISS announced a toric IOL, a cataract configuration of EVA NEXUS and updates to digital surgical planning.
Carl Zeiss Meditec ↗
